Home Pilots Singaporean gut microbiome firm AMILI scores $10.5M in Series A funding Pilots Singaporean gut microbiome firm AMILI scores $10.5M in Series A funding By - June 17, 2022 67 0 Facebook Twitter Pinterest WhatsApp It will use the funds to deepen its presence across Asia. RELATED ARTICLESMORE FROM AUTHOR Pilots Omada Health debuts on Nasdaq at $19 per share Pilots University of New South Wales trials brain game for chronic pain treatment Pilots Hims & Hers Health acquires European telemedicine platform Zava LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Derma AI Cureskin bags $20M Series B funding and more funding from India Pilots - March 15, 2024 0 CardioSignal scores $10M for heart disease detection technology Pilots - January 23, 2024 0 The rising role of smart technologies in chronic disease management Pilots - November 28, 2022 0 Q&A: Why medical device company Penumbra is betting on VR Pilots - October 28, 2022 0 Digital health investors weigh in on aftermath of Silicon Valley Bank collapse Pilots - March 31, 2023 0 POPULAR CATEGORIESPilots2366Applications834Testing285Collaborations15GitHub3
